Postdoctoral Research Fellow
Mount Sinai School of Medicine
New York, NY.

Mount Sinai School of Medicine
Department of Oncology/Hematology
One Gustave Levy Place, Box 1079
New York, NY
(212) 659-9074

2005 Ph.D. in Cancer Genetics
Institute of Cancer Research,
University of London, England

2001 B. Sc. Honours degree in Applied Biology. University of Newcastle upon Tyne,
Newcastle, England

September 2005-present
Postdoctoral Research fellow. Oncology/haematology, Mount Sinai School of Medicine, New York, NY.

February 2005 – August 2005
Postdoctoral research fellow in Molecular Carcinogenesis, Institute of Cancer Research, England

October 2001-January 2005
Ph.D. Student. Molecular Carcinogenesis, Institute of Cancer Research, laboratory of Prof. Colin Cooper. Carried out cDNA array CGH and expression profiling, to identify putative oncogenes and tumour suppressor genes involved in urological cancer progression. Identifying E2F3 as a bladder cancer an oncogene and the expression of which correlated with prostate cancer patient survival.

American Association for Cancer Research

Foster, C,S. Falconer, A. Dodson, A,R. Norman, A,R. Dennis, N. Dowe, A. Dearnley, D. Jhavar, S. Southgate, S. Eeles, R. Feber, A. Cooper, C,S. ‘Transcription Factor E2F3 Overexpressed in Prostate Cancer Independently Predicts Clinical Outcome’. (2004). Oncogene. 23 (35) : 5871-5879.

Feber, A . Clark, J. Goodwin, G. Dodson, A,R. Smith, P,H. Fletcher, A. Edwrads, S. Flhor, P. Falconer, A. Roe, T. Kovacs, G. Dennis, N. Fisher, C. Wooster, R. Huddart, R. Foster, C,S. Cooper, C,S. ‘Amplification and overexpression of E2F3 in bladder cancer’. (2004). Oncogene. 23 (8): 1627-1630.

Clark, J. Edwards, S. Feber, A. Flhor, P. John, M. Giddings, I. Crossland, S. Stratton, M,R. Wooster, R. Campbell, C. Cooper, C.S. ‘Genome-wide screening for complete genetic loss in prostate cancer by comparative hybridisation onto cDNA microarrays’. (2003). Oncogene. 22 (8) : 1247-1252.